Botox & Penile Injectables
Off-Label Botulinum Toxin for Glans Desensitization, Premature Ejaculation, and Related Uses
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- No FDA approval for penile/sexual indications; entirely off-label and investigational
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about botox & penile injectables in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Botulinum toxin (Botox/Dysport) and other injectables are being explored off-label around the male genitals: into the glans or frenular area to desensitize and delay ejaculation, into the bulbospongiosus muscle to dampen the ejaculatory reflex, and ('scrotox') into scrotal skin for cosmetic relaxation. Small trials report increased intravaginal ejaculatory latency, but the data are early, the effect is temporary, and these uses are neither FDA-approved nor guideline-endorsed. Hyaluronic-acid injection into the glans has also been studied for premature ejaculation, with some comparative trials favoring HA over botulinum toxin.
Investigational injections for sensitivity and ejaculation control, not approved, not standard.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Botulinum toxin blocks acetylcholine release at the neuromuscular junction. Injected into the bulbospongiosus muscle, it is theorized to inhibit the rhythmic contractions of the ejaculatory reflex; injected intradermally in the glans/frenulum, it is theorized to blunt sensory nerve-terminal activity and reduce hypersensitivity. The effect is inherently temporary, lasting until the toxin's action resolves over weeks to months.
What the early trials show
Small randomized and pilot studies report measurable but modest, temporary increases in intravaginal ejaculatory latency time after botulinum injection at various sites (glans, root, bulbospongiosus), with one study moving mean IELT from roughly 1.8 to 3.9 minutes; a systematic review/meta-analysis of bulbospongiosus injection found a signal but flagged limited, heterogeneous data. Comparative work suggests hyaluronic-acid glans injection may outperform botulinum toxin for premature ejaculation. The central caution from investigators themselves: over-desensitization is a real risk that can reduce pleasure, and none of these uses has the evidence base or regulatory standing of established PE therapies (SSRIs, topical anesthetics, behavioral methods).
Safety in detail
Genital botulinum-toxin and filler injections for sexual indications are off-label and investigational. Excessive glans desensitization can unacceptably impair sexual pleasure, and improper injection risks bruising, infection, and functional effects. These are not approved or standard treatments; precise technique and informed consent are essential.
What people get wrong
Often saidBotox permanently fixes premature ejaculation
ActuallyAny effect is temporary and wears off; these injections are investigational, not a durable cure.
Often saidGlans Botox safely makes you last longer with no downside
ActuallyOver-desensitization can unacceptably reduce sexual pleasure, and the procedure is off-label with limited safety data.
Often saidThese injectables are approved sexual-health treatments
ActuallyNone are FDA-approved for penile/sexual indications; they are off-label and investigational.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Indications explored
- Premature ejaculation, glans hypersensitivity, scrotal cosmesis
- Sites
- Glans/frenulum, bulbospongiosus, root of penis, scrotal skin
- Effect
- Temporary; wears off as toxin effect resolves
- Status
- Off-label, investigational, not guideline-endorsed
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Botox & Penile Injectables. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Botulinum toxin into bulbospongiosus for lifelong PE, systematic review/meta-analysis2024-2025
Pooled small trials: signal for increased IELT but limited, heterogeneous evidence; not definitive.
Frenular/glans botulinum injection for PE2024
Intradermal glans/frenular injection increased latency in a treatment cohort; temporary effect, off-label.
HA vs botulinum-A injection for PE, Scientific Reports2025
Comparative study finding greater improvement with hyaluronic-acid glans injection than botulinum toxin.